Dear Healthcare Professional,
As part of Risk Management Plan (RMP) conducted by pharmaceutical industry, PT Roche Indonesia communicate safety information for doctor related to Esbriet (Pirfenidone).
Esbriet (Pirfenidone) is medicine for mild to moderate Idiopathic Pulmonary Fibrosis (IPF) in adult. This safety information contains important elements for Esbriet (Pirfenidone) use especially related to photosensitivity and hepatic function.
For more detail information can be found in the Safety Information for Doctor from PT Roche Indonesia.
National Pharmacovigilance Center
National Agency of Drug and Food Control (NADFC)
Download : Informasi Keamanan Bagi Dokter Terkait Penggunaan ESBRIET (pirfenidone).pdf